Global Brucella Abortus Vaccine Market Insights, Forecast to 2025

Table of Contents

1 Study Coverage

• 1.1 Brucella Abortus Vaccine Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Brucella Abortus Vaccine Market Size Growth Rate by Product
  • 1.4.2 DNA Vaccines
  • 1.4.3 Subunit Vaccines
  • 1.4.4 Vector Vaccines
  • 1.4.5 B. Abortus Recombinant Mutants
  • 1.4.6 Others
• 1.5 Market by End User
  • 1.5.1 Global Brucella Abortus Vaccine Market Size Growth Rate by End User
  • 1.5.2 Cattles
  • 1.5.3 Sheep
  • 1.5.4 Pigs
  • 1.5.5 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Brucella Abortus Vaccine Market Size
  • 2.1.1 Global Brucella Abortus Vaccine Revenue 2014-2025
  • 2.1.2 Global Brucella Abortus Vaccine Sales 2014-2025
• 2.2 Brucella Abortus Vaccine Growth Rate by Regions
  • 2.2.1 Global Brucella Abortus Vaccine Sales by Regions
  • 2.2.2 Global Brucella Abortus Vaccine Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Brucella Abortus Vaccine Sales by Manufacturers
  • 3.1.1 Brucella Abortus Vaccine Sales by Manufacturers
  • 3.1.2 Brucella Abortus Vaccine Sales Market Share by Manufacturers
  • 3.1.3 Global Brucella Abortus Vaccine Market Concentration Ratio (CR5 and HHI)
• 3.2 Brucella Abortus Vaccine Revenue by Manufacturers
  • 3.2.1 Brucella Abortus Vaccine Revenue by Manufacturers (2014-2019)
  • 3.2.2 Brucella Abortus Vaccine Revenue Share by Manufacturers (2014-2019)
• 3.3 Brucella Abortus Vaccine Price by Manufacturers
• 3.4 Brucella Abortus Vaccine Manufacturing Base Distribution, Product Types
  • 3.4.1 Brucella Abortus Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Brucella Abortus Vaccine Product Type
  • 3.4.3 Date of International Manufacturers Enter into Brucella Abortus Vaccine Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Brucella Abortus Vaccine Sales by Product
• 4.2 Global Brucella Abortus Vaccine Revenue by Product
• 4.3 Brucella Abortus Vaccine Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Brucella Abortus Vaccine Breakdown Data by End User

6 North America

• 6.1 North America Brucella Abortus Vaccine by Countries
  • 6.1.1 North America Brucella Abortus Vaccine Sales by Countries
  • 6.1.2 North America Brucella Abortus Vaccine Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Brucella Abortus Vaccine by Product
• 6.3 North America Brucella Abortus Vaccine by End User

7 Europe

• 7.1 Europe Brucella Abortus Vaccine by Countries
  • 7.1.1 Europe Brucella Abortus Vaccine Sales by Countries
  • 7.1.2 Europe Brucella Abortus Vaccine Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Brucella Abortus Vaccine by Product
• 7.3 Europe Brucella Abortus Vaccine by End User

8 Asia Pacific

• 8.1 Asia Pacific Brucella Abortus Vaccine by Countries
  • 8.1.1 Asia Pacific Brucella Abortus Vaccine Sales by Countries
  • 8.1.2 Asia Pacific Brucella Abortus Vaccine Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Brucella Abortus Vaccine by Product
• 8.3 Asia Pacific Brucella Abortus Vaccine by End User

9 Central & South America

• 9.1 Central & South America Brucella Abortus Vaccine by Countries
  • 9.1.1 Central & South America Brucella Abortus Vaccine Sales by Countries
  • 9.1.2 Central & South America Brucella Abortus Vaccine Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Brucella Abortus Vaccine by Product
• 9.3 Central & South America Brucella Abortus Vaccine by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Brucella Abortus Vaccine by Countries
  • 10.1.1 Middle East and Africa Brucella Abortus Vaccine Sales by Countries
  • 10.1.2 Middle East and Africa Brucella Abortus Vaccine Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Brucella Abortus Vaccine by Product
• 10.3 Middle East and Africa Brucella Abortus Vaccine by End User

11 Company Profiles

• 11.1 Zoetis
  • 11.1.1 Zoetis Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Zoetis Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Zoetis Brucella Abortus Vaccine Products Offered
  • 11.1.5 Zoetis Recent Development
• 11.2 CEVA
  • 11.2.1 CEVA Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 CEVA Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 CEVA Brucella Abortus Vaccine Products Offered
  • 11.2.5 CEVA Recent Development
• 11.3 Merck Animal Health
  • 11.3.1 Merck Animal Health Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Merck Animal Health Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Merck Animal Health Brucella Abortus Vaccine Products Offered
  • 11.3.5 Merck Animal Health Recent Development
• 11.4 Biovet
  • 11.4.1 Biovet Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Biovet Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Biovet Brucella Abortus Vaccine Products Offered
  • 11.4.5 Biovet Recent Development
• 11.5 CAVAC
  • 11.5.1 CAVAC Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 CAVAC Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 CAVAC Brucella Abortus Vaccine Products Offered
  • 11.5.5 CAVAC Recent Development
• 11.6 JOVAC
  • 11.6.1 JOVAC Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 JOVAC Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 JOVAC Brucella Abortus Vaccine Products Offered
  • 11.6.5 JOVAC Recent Development
• 11.7 Merial
  • 11.7.1 Merial Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Merial Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Merial Brucella Abortus Vaccine Products Offered
  • 11.7.5 Merial Recent Development
• 11.8 Colorado Serum Company
  • 11.8.1 Colorado Serum Company Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Colorado Serum Company Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Colorado Serum Company Brucella Abortus Vaccine Products Offered
  • 11.8.5 Colorado Serum Company Recent Development
• 11.9 VECOL
  • 11.9.1 VECOL Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 VECOL Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 VECOL Brucella Abortus Vaccine Products Offered
  • 11.9.5 VECOL Recent Development
• 11.10 Tecnovax
  • 11.10.1 Tecnovax Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Tecnovax Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Tecnovax Brucella Abortus Vaccine Products Offered
  • 11.10.5 Tecnovax Recent Development
• 11.11 Indian Immunologicals
• 11.12 Vetal
• 11.13 Dollvet
• 11.14 Centro Diagnostico Veterinario
• 11.15 Onderstepoort Biological Products
• 11.16 Institute of Animal Health and Veterinary Biologicals
• 11.17 Biogenesis Bago
• 11.18 Instituto Rosenbusch
• 11.19 SYVA Laboratorios
• 11.20 CZ Veterinaria
• 11.21 Hester Biosciences
• 11.22 Qilu Animal Health

12 Future Forecast

• 12.1 Brucella Abortus Vaccine Market Forecast by Regions
  • 12.1.1 Global Brucella Abortus Vaccine Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Brucella Abortus Vaccine Revenue Forecast by Regions 2019-2025
• 12.2 Brucella Abortus Vaccine Market Forecast by Product
  • 12.2.1 Global Brucella Abortus Vaccine Sales Forecast by Product 2019-2025
  • 12.2.2 Global Brucella Abortus Vaccine Revenue Forecast by Product 2019-2025
• 12.3 Brucella Abortus Vaccine Market Forecast by End User
• 12.4 North America Brucella Abortus Vaccine Forecast
• 12.5 Europe Brucella Abortus Vaccine Forecast
• 12.6 Asia Pacific Brucella Abortus Vaccine Forecast
• 12.7 Central & South America Brucella Abortus Vaccine Forecast
• 12.8 Middle East and Africa Brucella Abortus Vaccine Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Brucella Abortus Vaccine Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details